Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products (Nasdaq: UTMD) announced that its Board of Directors approved a quarterly cash dividend of $0.31 per share of common stock.
Rhea-AI Summary
Utah Medical Products (Nasdaq: UTMD) announced that its Board of Directors approved a quarterly cash dividend of $0.31 per share of common stock. The dividend is payable on October 5, 2026 to shareholders of record as of September 17, 2026, representing a 1.6% increase over the dividend declared in the same quarter of the prior year.
Positive
- Quarterly dividend set at $0.31 per share
- 1.6% YoY increase in quarterly dividend for the same quarter
- Record date September 17, 2026 and payment date October 5, 2026 established
Negative
- None.
Details
News Market Reaction – UTMD
In the Aug 4 session, UTMD declined 0.62%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.